Comparison between Astec LifeSciences IPO and Thinksoft Global IPO.
Astec LifeSciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thinksoft Global IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Astec LifeSciences IPO is up to ₹61.50 Cr whereas the issue size of the Thinksoft Global IPO is up to ₹45.58 Cr. The final issue price of Astec LifeSciences IPO is ₹82.00 per share and of Thinksoft Global IPO is ₹125.00 per share.
| Astec LifeSciences IPO | Thinksoft Global IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹77.00 per share | ₹115.00 per share |
| Issue Price (Upper) | ₹82.00 per share | ₹125.00 per share |
| Issue Price (Final) | ₹82.00 per share | ₹125.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 75 shares | 50 shares |
| Fresh Issue Size | 75,00,150 shares | 13,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹61.50 Cr | up to ₹16.88 Cr |
| OFS Issue Size | 0 shares | 22,96,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹28.70 Cr |
| Issue Size Total | 75,00,150 shares | 36,46,000 shares |
| Issue Size Total (Amount) | up to ₹61.50 Cr | up to ₹45.58 Cr |
Astec LifeSciences IPO opens on Oct 29, 2009, while Thinksoft Global IPO opens on Sep 22, 2009. The closing date of Astec LifeSciences IPO and Thinksoft Global IPO is Nov 04, 2009, and Oct 01, 2009, respectively.
| Astec LifeSciences IPO | Thinksoft Global IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 29, 2009 | Sep 22, 2009 |
| Issue Close | Nov 04, 2009 | Oct 01, 2009 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Nov 25, 2009 | Oct 26, 2009 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Astec LifeSciences IPO P/E ratio is , as compared to Thinksoft Global IPO P/E ratio of .
| Astec LifeSciences IPO | Thinksoft Global IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 0.9999 | 61.47 | ||||
| Promoter Shareholding (Post-Issue) | 55.69 | 53.21 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹138.82 Cr. | ₹125.64 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 35.15 | 31.76 |
In the Astec LifeSciences IPO Retail Individual Investors (RII) are offered 25,90,000 shares while in Thinksoft Global IPO retail investors are offered 25,90,000 shares. Qualified Institutional Buyers (QIB) are offered 37,00,000 shares in Astec LifeSciences IPO and 18,23,000 shares in Thinksoft Global IPO.
| Astec LifeSciences IPO | Thinksoft Global IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 37,00,000 shares | 18,23,000 shares |
| NII | 11,10,000 shares | 5,46,900 shares |
| RII | 25,90,000 shares | 12,76,100 shares |
| Employee | 1,00,000 shares | |
| Others | ||
| Total | 75,00,000 shares | 36,46,000 shares |
Astec LifeSciences IPO subscribed 1.56x in total, whereas Thinksoft Global IPO subscribed 2.57x.
| Astec LifeSciences IPO | Thinksoft Global IPO | |
|---|---|---|
| QIB (times) | 0.61x | 0.31x |
| NII (times) | 3.00x | 6.05x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.36x | 4.31x |
| Employee (times) | 0.50x | |
| Other (times) | ||
| Total (times) | 1.56x | 2.57x |
